James Jiqi Wang

机构：Tongji Hospital, Huazhong University of Science and Technology · ORCID：0000-0002-8878-668X

发表论文 17 篇 · 总被引 228 次 · h-index 8

代表论文

• Good or bad: Application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities (2020 · Pharmacology & Therapeutics · 被引 58)
• Immunopathogenesis and immunomodulatory therapy for myocarditis (2023 · Science China Life Sciences · 被引 43)
• Spatiotemporal transcriptomics elucidates the pathogenesis of fulminant viral myocarditis (2025 · Signal Transduction and Targeted Therapy · 被引 29)
• Molecular recognition and activation of the prostacyclin receptor by anti-pulmonary arterial hypertension drugs (2024 · Science Advances · 被引 24)
• Molecular mechanisms of urate transport by the native human URAT1 and its inhibition by anti-gout drugs (2025 · Cell Discovery · 被引 17)
• FBN1 Splice-Altering Mutations in Marfan Syndrome: A Case Report and Literature Review (2022 · Genes · 被引 13)